Skip to main content
. 2017 Jul 31;8(35):59397–59407. doi: 10.18632/oncotarget.19720

Table 3. Genotypes of SH2B3 and SMARCA4 polymorphisms and CAD risk associations (age-adjusted).

Men Women
SNP Model Genotype Control Case OR (95% CI) p Control Case OR (95% CI) p
rs3742003 Codominant A/A 319 (83.1%) 224 (77%) 1 0.076 246 (82%) 136 (82.4%) 1 0.960
G/A 63 (16.4%) 67 (23%) 1.57 (1.01-2.42) 52 (17.3%) 28 (17%) 0.99 (0.53-1.85)
G/G 2 (0.5%) 0 (0%) 0.00 (0.00-NA) 2 (0.7%) 1 (0.6%) 0.59 (0.02-20.73)
Dominant A/A 319 (83.1%) 224 (77%) 1 0.054 246 (82%) 136 (82.4%) 1 0.950
G/A-G/G 65 (16.9%) 67 (23%) 1.53 (0.99-2.36) 54 (18%) 29 (17.6%) 0.98 (0.53-1.81)
Recessive A/A-G/A 382 (99.5%) 291 (100%) 1 0.300 298 (99.3%) 164 (99.4%) 1 0.770
G/G 2 (0.5%) 0 (0%) 0.00 (0.00-NA) 2 (0.7%) 1 (0.6%) 0.59 (0.02-20.72)
Overdominant A/A-G/G 321 (83.6%) 224 (77%) 1 0.041* 248 (82.7%) 137 (83%) 1 0.990
G/A 63 (16.4%) 67 (23%) 1.57 (1.02-2.43) 52 (17.3%) 28 (17%) 0.99 (0.53-1.85)
Log-additive --- --- --- 1.47 (0.96-2.23) 0.074 --- --- 0.97 (0.53-1.75) 0.910
 rs12580300 Codominant G/G 134 (35%) 98 (33.7%) 1 0.820 99 (33%) 63 (38.2%) 1 0.043*
G/A 179 (46.7%) 147 (50.5%) 1.08 (0.73-1.59) 150 (50%) 82 (49.7%) 0.66 (0.39-1.13)
A/A 70 (18.3%) 46 (15.8%) 0.93 (0.56-1.55) 51 (17%) 20 (12.1%) 0.39 (0.18-0.85)
Dominant G/G 134 (35%) 98 (33.7%) 1 0.840 99 (33%) 63 (38.2%) 1 0.039*
G/A-A/A 249 (65%) 193 (66.3%) 1.04 (0.72-1.49) 201 (67%) 102 (61.8%) 0.59 (0.35-0.97)
Recessive G/G-G/A 313 (81.7%) 245 (84.2%) 1 0.610 249 (83%) 145 (87.9%) 1 0.046
A/A 70 (18.3%) 46 (15.8%) 0.89 (0.56-1.41) 51 (17%) 20 (12.1%) 0.50 (0.24-1.00)
Overdominant G/G-A/A 204 (53.3%) 144 (49.5%) 1 0.570 150 (50%) 83 (50.3%) 1 0.590
G/A 179 (46.7%) 147 (50.5%) 1.11 (0.78-1.56) 150 (50%) 82 (49.7%) 0.87 (0.54-1.42)
Log-additive --- --- --- 0.98 (0.77-1.26) 0.890 --- --- 0.63 (0.44-0.91) 0.012*
 rs7309325 Codominant T/T 320 (83.5%) 226 (77.7%) 1 0.100 248 (82.7%) 137 (83.5%) 1 0.880
G/T 62 (16.2%) 65 (22.3%) 1.55 (1.00-2.40) 52 (17.3%) 26 (15.8%) 1.02 (0.54-1.92)
G/G 1 (0.3%) 0 (0%) 0.00 (0.00-NA) 0 (0%) 1 (0.6%) NA (0.00-NA)
Dominant T/T 320 (83.5%) 226 (77.7%) 1 0.055 248 (82.7%) 137 (83.5%) 1 0.930
G/T-G/G 63 (16.4%) 65 (22.3%) 1.53 (0.99-2.37) 52 (17.3%) 27 (16.5%) 1.03 (0.55-1.93)
Recessive T/T-G/T 382 (99.7%) 291 (100%) 1 0.420 300 (100%) 163 (99.4%) 1 0.620
G/G 1 (0.3%) 0 (0%) 0.00 (0.00-NA) 0 (0%) 1 (0.6%) NA (0.00-NA)
Overdominant T/T-G/G 321 (83.8%) 226 (77.7%) 1 0.047* 248 (82.7%) 138 (84.2%) 1 0.960
G/T 62 (16.2%) 65 (22.3%) 1.56 (1.01-2.41) 52 (17.3%) 26 (15.8%) 1.02 (0.54-1.91)
Log-additive --- --- --- 1.49 (0.97-2.29) 0.066 --- --- 1.04 (0.56-1.94) 0.900
T/T 94 (24.4%) 78 (26.8%) 1 72 (24%) 44 (26.7%) 1 0.022*
Codominant C/T 196 (50.9%) 150 (51.5%) 0.80 (0.53-1.21) 0.480 152 (50.7%) 93 (56.4%) 0.82 (0.46-1.47)
C/C 95 (24.7%) 63 (21.6%) 0.76 (0.46-1.25) 76 (25.3%) 28 (17%) 0.39 (0.19-0.81)
Dominant T/T 94 (24.4%) 78 (26.8%) 1 0.240 72 (24%) 44 (26.7%) 1 0.140
C/T-C/C 291 (75.6%) 213 (73.2%) 0.79 (0.53-1.17) 228 (76%) 121 (73.3%) 0.66 (0.38-1.15)
Recessive T/T-C/T 290 (75.3%) 228 (78.3%) 1 0.560 224 (74.7%) 137 (83%) 1 0.007*
 rs2078863 C/C 95 (24.7%) 63 (21.6%) 0.89 (0.59-1.34) 76 (25.3%) 28 (17%) 0.44 (0.24-0.82)
Overdominant T/T-C/C 189 (49.1%) 141 (48.5%) 1 0.580 148 (49.3%) 72 (43.6%) 1 0.330
C/T 196 (50.9%) 150 (51.5%) 0.91 (0.64-1.28) 152 (50.7%) 93 (56.4%) 1.27 (0.78-2.06)
Log-additive --- --- --- 0.87 (0.68-1.12) 0.270 --- --- 0.64 (0.44-0.91) 0.012*
rs11879293 G/G 205 (53.5%) 176 (60.5%) 1 0.018* 160 (53.3%) 86 (52.1%) 1 0.760
Codominant G/A 148 (38.6%) 101 (34.7%) 0.68 (0.47-0.99) 125 (41.7%) 68 (41.2%) 0.83 (0.50-1.37)
A/A 30 (7.8%) 14 (4.8%) 0.41 (0.19-0.89) 15 (5%) 11 (6.7%) 0.93 (0.35-2.46)
Dominant G/G 205 (53.5%) 176 (60.5%) 1 0.012* 160 (53.3%) 86 (52.1%) 1 0.490
G/A-A/A 178 (46.5%) 115 (39.5%) 0.64 (0.45-0.91) 140 (46.7%) 79 (47.9%) 0.84 (0.52-1.37)
Recessive G/G-G/A 353 (92.2%) 277 (95.2%) 1 0.049* 285 (95%) 154 (93.3%) 1 0.990
A/A 30 (7.8%) 14 (4.8%) 0.48 (0.23-1.02) 15 (5%) 11 (6.7%) 1.01 (0.39-2.60)
Overdominant G/G-A/A 235 (61.4%) 190 (65.3%) 1 0.110 175 (58.3%) 97 (58.8%) 1 0.470
G/A 148 (38.6%) 101 (34.7%) 0.75 (0.52-1.07) 125 (41.7%) 68 (41.2%) 0.84 (0.51-1.37)
Log-additive --- --- --- 0.66 (0.50-0.89) 0.005* --- --- 0.90 (0.61-1.32) 0.580
rs12232780 Codominant G/G 215 (56.1%) 198 (68%) 1 0.002* 0.970
G/A 146 (38.1%) 84 (28.9%) 0.56 (0.39-0.82) 191 (63.7%) 94 (57%) 1
A/A 22 (5.7%) 9 (3.1%) 0.33 (0.13-0.84) 102 (34%) 67 (40.6%) 1.03 (0.62-1.71)
Dominant G/G 215 (56.1%) 198 (68%) 1 0.001* 7 (2.3%) 4 (2.4%) 0.86 (0.19-4.01) 0.930
G/A-A/A 168 (43.9%) 93 (32%) 0.53 (0.37-0.76) 191 (63.7%) 94 (57%) 1
Recessive G/G-G/A 361 (94.3%) 282 (96.9%) 1 0.047* 109 (36.3%) 71 (43%) 1.02 (0.62-1.68) 0.840
A/A 22 (5.7%) 9 (3.1%) 0.41 (0.16-1.03) 293 (97.7%) 161 (97.6%) 1
Overdominant G/G-A/A 237 (61.9%) 207 (71.1%) 1 0.007* 7 (2.3%) 4 (2.4%) 0.85 (0.19-3.92) 0.880
G/A 146 (38.1%) 84 (28.9%) 0.60 (0.42-0.88) 198 (66%) 98 (59.4%) 1
Log-additive --- --- --- 0.57 (0.41-0.78) 0.000* 102 (34%) 67 (40.6%) 1.04 (0.63-1.72)
Codominant C/C 188 (49.5%) 129 (44.3%) 1 0.013* 152 (50.7%) 78 (47.3%) 1 0.670
T/C 171 (45%) 128 (44%) 1.05 (0.73-1.52) 130 (43.3%) 73 (44.2%) 1.15 (0.69-1.90)
T/T 21 (5.5%) 34 (11.7%) 2.69 (1.36-5.32) 18 (6%) 14 (8.5%) 1.47 (0.59-3.66)
 rs2072382 Dominant C/C 188 (49.5%) 129 (44.3%) 1 0.270 152 (50.7%) 78 (47.3%) 1 0.470
T/C-T/T 192 (50.5%) 162 (55.7%) 1.21 (0.86-1.72) 148 (49.3%) 87 (52.7%) 1.20 (0.74-1.94)
Recessive C/C-T/C 359 (94.5%) 257 (88.3%) 1 0.003 282 (94%) 151 (91.5%) 1 0.470
T/T 21 (5.5%) 34 (11.7%) 2.62 (1.36-5.06) 18 (6%) 14 (8.5%) 1.38 (0.57-3.32)
Overdominant C/C-T/T 209 (55%) 163 (56%) 1 0.620 170 (56.7%) 92 (55.8%) 1 0.740
T/C 171 (45%) 128 (44%) 0.91 (0.65-1.30) 130 (43.3%) 73 (44.2%) 1.09 (0.67-1.77)
Log-additive --- --- --- 1.35 (1.02-1.77) 0.034 --- --- 1.19 (0.81-1.73) 0.380

OR = odds ratio; 95 % CI = 95 % confidence interval

p values were calculated by unconditional logistic regression adjusted for age

*p < 0.05 indicates statistical significance